Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G Schmalzing

Showing results (41-50 of 44) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 44 results.
European Journal of Pharmacology|July 31, 1998
NF279: a novel potent and selective antagonist of P2X receptor-mediated responsesS Damer, B Niebel, S Czeche, et al.
FEBS Letters|December 19, 1994
Molecular characterization of human and bovine endothelin converting enzyme (ECE-1)M Schmidt, B Kröger, E Jacob, et al.
Infection and Immunity|November 14, 2001
Lysine and polyamines are substrates for transglutamination of Rho by the Bordetella dermonecrotic toxinG Schmidt, U M Goehring, J Schirmer, et al.
European Journal of Pharmacology|January 29, 2000
The novel pyridoxal-5'-phosphate derivative PPNDS potently antagonizes activation of P2X(1) receptorsG Lambrecht, J Rettinger, H G Bäumert, et al.
Pageof 5

Showing results (41-50 of 44) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 44 results.
European Journal of Pharmacology|July 31, 1998
NF279: a novel potent and selective antagonist of P2X receptor-mediated responsesS Damer, B Niebel, S Czeche, et al.
FEBS Letters|December 19, 1994
Molecular characterization of human and bovine endothelin converting enzyme (ECE-1)M Schmidt, B Kröger, E Jacob, et al.
Infection and Immunity|November 14, 2001
Lysine and polyamines are substrates for transglutamination of Rho by the Bordetella dermonecrotic toxinG Schmidt, U M Goehring, J Schirmer, et al.
European Journal of Pharmacology|January 29, 2000
The novel pyridoxal-5'-phosphate derivative PPNDS potently antagonizes activation of P2X(1) receptorsG Lambrecht, J Rettinger, H G Bäumert, et al.
Pageof 5